Associated factors with persistent airflow limitation in asthma in U-BIOPRED

A. Wagener, D. Gibeon, X. Yang, A. Sousa, J. Corfield, D. Shaw, S. Fowler, L. Fleming, J. Riley, L. Jeyasingham, A. Rowe, K. Fichtner, G. Roberts, P. Bakke, F. Singer, T. Geiser, U. Frey, I. Horvarth, R. Polosa, K. Bønnelykke, N. Krug, R. Middelveld, S. E. Dahlen, B. Dahlen, G. Hedlin, S. Hashimoto, B. Nordlund, J. Musial, A. Woodcock, C. Murray, L. Pahus, P. Chanez, D. Myles, C. Compton, T. W. Higenbottam, P. Montuschi, J. Vestbo, L. Larsson, T. Sandstrom, H. Bisgaard, S. S. Wagers, P. H. Howarth, E. H. Bel, R. Djukanovic, F. Chung, P. Sterk (London, Nottingham, Manchester, Ingelheim am Rhein, Southampton, Budapest, Horsham, United Kingdom; Amsterdam, Netherlands; Lund, Stockholm, Umeå, Sweden; Bergen, Norway; Bern, Switzerland; Catania, Rome, Italy; Copenhagen, Hvidovre, Denmark; Hannover, Germany; Krakow, Poland; Marseille, France; Maasmechelen, Belgium)

Source: Annual Congress 2013 –Studies of asthma in man
Session: Studies of asthma in man
Session type: Poster Discussion
Number: 3142
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Wagener, D. Gibeon, X. Yang, A. Sousa, J. Corfield, D. Shaw, S. Fowler, L. Fleming, J. Riley, L. Jeyasingham, A. Rowe, K. Fichtner, G. Roberts, P. Bakke, F. Singer, T. Geiser, U. Frey, I. Horvarth, R. Polosa, K. Bønnelykke, N. Krug, R. Middelveld, S. E. Dahlen, B. Dahlen, G. Hedlin, S. Hashimoto, B. Nordlund, J. Musial, A. Woodcock, C. Murray, L. Pahus, P. Chanez, D. Myles, C. Compton, T. W. Higenbottam, P. Montuschi, J. Vestbo, L. Larsson, T. Sandstrom, H. Bisgaard, S. S. Wagers, P. H. Howarth, E. H. Bel, R. Djukanovic, F. Chung, P. Sterk (London, Nottingham, Manchester, Ingelheim am Rhein, Southampton, Budapest, Horsham, United Kingdom; Amsterdam, Netherlands; Lund, Stockholm, Umeå, Sweden; Bergen, Norway; Bern, Switzerland; Catania, Rome, Italy; Copenhagen, Hvidovre, Denmark; Hannover, Germany; Krakow, Poland; Marseille, France; Maasmechelen, Belgium). Associated factors with persistent airflow limitation in asthma in U-BIOPRED. Eur Respir J 2013; 42: Suppl. 57, 3142

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Factors associated with irreversible airway obstruction in patients with asthma
Source: International Congress 2014 – Asthma or COPD: comorbid condition or a poorly understood single disease?
Year: 2014

Biomarkers for sputum eosinophilia in mild-moderate and severe adult-onset asthma patients
Source: International Congress 2014 – Systemic and airway biomarkers
Year: 2014


An extensive function evaluation in severe asthma with airflow limitation
Source: International Congress 2014 – Asthma: still a heterogeneous condition!
Year: 2014


Obesity influences inflammatory phenotype mainly in early onset severe asthmatics
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014

Characterisation of asthma patients with persistent airflow obstruction
Source: International Congress 2016 – Clinical studies in asthma and immunology
Year: 2016


Biomarkers of obesity associated with severe atopic asthma
Source: International Congress 2015 – Asthma mechanisms and management
Year: 2015

Markers of eosinophilic airway inflammation in patients with severe and mild to moderate asthma
Source: International Congress 2016 – Airway biomarkers
Year: 2016

Importance of concomitant local and systemic eosinophilia in uncontrolled asthma
Source: International Congress 2014 – Biomarkers of asthma control
Year: 2014


Predictors of exacerbations in asthma
Source: International Congress 2015 – Clinical assessment in asthma and COPD
Year: 2015


U-BIOPRED asthma cohort: Inflammatory markers and corticosteroid use
Source: Annual Congress 2013 –Novel mechanisms for established drugs for asthma and COPD management
Year: 2013



Phenotypic characteristics of asthma with small airways involvement
Source: International Congress 2016 – Notable abstracts on clinical problems related to asthma
Year: 2016

Implication of IL-18 in the chronic inflammation of severe refractory asthma
Source: International Congress 2014 – Systemic and airway biomarkers
Year: 2014

Factors associated with uncontrolled asthma in patients with aspirin-exacerbated respiratory disease (AERD)
Source: International Congress 2014 – Asthma: still a heterogeneous condition!
Year: 2014


Induced sputum lipid mediators in severe asthma
Source: International Congress 2016 – Translational studies in lung disease
Year: 2016

Risk factors of fixed airway obstruction in elderly patients with asthma
Source: International Congress 2016 – Asthma: mechanisms and biomarkers that promote clinical understanding
Year: 2016

Analysis of the inflammatory profile of children with controlled and uncontrolled severe asthma
Source: International Congress 2016 – Drugs, bugs, BMI, and other problems in paediatric asthma
Year: 2016


Psychophysiology of depression in bronchial asthma
Source: Annual Congress 2013 –Phenotyping asthma: clinical severity, comorbid conditions response to treatment?
Year: 2013


Characteristics of the adult corticosteroid-dependent severe asthma in UBIOPRED consortium
Source: International Congress 2014 – Novel targets and drugs for asthma and COPD
Year: 2014

The usefulness of FeNO and the mannitol test in detecting airway eosinophilia in asthma patients with uncontrolled symptoms
Source: International Congress 2014 – Biomarkers of asthma control
Year: 2014


The first U-BIOPRED sputum handprint of severe asthma
Source: International Congress 2015 – Respiratory translational research: novel mechanisms, diagnostic markers and Space Odyssey
Year: 2015